Artificial intelligence-based decision support system for risk stratification and early detection of heart failure in primary and secondary care
The overarching AIM of this Research and Innovation Action is to develop and clinically validate a truly innovative AI-based Decision Support System (STRATIFYHF) for predicting risk of HF, facilitating its early diagnosis and progression prediction that will radically change how HF is managed in both primary and secondary care. The DSS integrates patient-centred data obtained using existing and novel technologies, a digital patient library and AI-based algorithms and computational modelling.
Prof. Nenad Filipovic has presented lecture with title: Trustworthy AI in Cardiovascular Medicine: Bias, Regulation, Validation & Equity with new results from STRATIFYHF project, on the...
BioIRC researchers participated in the 20th International Symposium on Organizational Sciences (SymOrg 2026), where they presented three posters from the STRATIFYHF project: Integrating Biomarkers...
On May 8th, our researchers have presented the ongoing activities on STRATIFYHF project at the Mediterranea University of Reggio Calabria, Italy. This has been a great opportunity to spread the word...